Pinebridge Investments L.P. cut its stake in Colgate-Palmolive (NYSE:CL) by 90.9% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 11,017 shares of the company’s stock after selling 109,668 shares during the period. Pinebridge Investments L.P.’s holdings in Colgate-Palmolive were worth $816,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently modified their holdings of the business. American Beacon Advisors Inc. purchased a new position in shares of Colgate-Palmolive during the first quarter valued at approximately $102,000. Proficio Capital Partners LLC increased its position in shares of Colgate-Palmolive by 16.9% during the first quarter. Proficio Capital Partners LLC now owns 1,432 shares of the company’s stock valued at $107,000 after acquiring an additional 207 shares in the last quarter. OLD Second National Bank of Aurora bought a new stake in shares of Colgate-Palmolive during the second quarter valued at approximately $109,000. Harbour Capital Advisors LLC bought a new stake in shares of Colgate-Palmolive during the first quarter valued at approximately $121,000. Finally, Hanson & Doremus Investment Management increased its position in shares of Colgate-Palmolive by 4.5% during the second quarter. Hanson & Doremus Investment Management now owns 1,630 shares of the company’s stock valued at $121,000 after acquiring an additional 70 shares in the last quarter. Institutional investors and hedge funds own 72.96% of the company’s stock.
CL has been the subject of several analyst reports. Zacks Investment Research raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $80.00 price target for the company in a research report on Monday, September 25th. SunTrust Banks raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and lifted their target price for the stock from $65.00 to $85.00 in a research report on Wednesday, October 11th. KeyCorp reaffirmed a “hold” rating on shares of Colgate-Palmolive in a research report on Monday, October 16th. Royal Bank Of Canada reiterated a “hold” rating and set a $74.00 price target on shares of Colgate-Palmolive in a research note on Sunday, October 8th. Finally, Jefferies Group restated a “hold” rating and set a $79.00 target price on shares of Colgate-Palmolive in a research note on Thursday, September 28th. Two research analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and four have issued a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $76.04.
In other Colgate-Palmolive news, insider Victoria L. Dolan sold 9,000 shares of the company’s stock in a transaction that occurred on Tuesday, November 14th. The shares were sold at an average price of $73.41, for a total transaction of $660,690.00. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Stephen I. Sadove sold 20,780 shares of the stock in a transaction on Monday, November 6th. The stock was sold at an average price of $70.52, for a total transaction of $1,465,405.60. Following the completion of the sale, the director now owns 36,268 shares in the company, valued at approximately $2,557,619.36. The disclosure for this sale can be found here. Insiders have sold a total of 173,673 shares of company stock worth $12,629,293 in the last 90 days. 1.02% of the stock is currently owned by company insiders.
Colgate-Palmolive (NYSE CL) traded down $1.05 during trading hours on Thursday, reaching $73.20. 3,696,241 shares of the company were exchanged, compared to its average volume of 3,606,393. Colgate-Palmolive has a 12 month low of $63.43 and a 12 month high of $77.27. The company has a debt-to-equity ratio of 24.42, a current ratio of 1.23 and a quick ratio of 0.92. The stock has a market capitalization of $64,280.00, a PE ratio of 25.99, a price-to-earnings-growth ratio of 3.42 and a beta of 0.81.
Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, October 27th. The company reported $0.73 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.73. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The company had revenue of $3.97 billion during the quarter, compared to analysts’ expectations of $3.94 billion. During the same quarter in the prior year, the company posted $0.73 earnings per share. Colgate-Palmolive’s revenue for the quarter was up 2.8% compared to the same quarter last year. equities analysts anticipate that Colgate-Palmolive will post 2.88 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Wednesday, November 15th. Shareholders of record on Monday, October 23rd were paid a dividend of $0.40 per share. The ex-dividend date was Friday, October 20th. This represents a $1.60 dividend on an annualized basis and a yield of 2.19%. Colgate-Palmolive’s payout ratio is 61.78%.
COPYRIGHT VIOLATION NOTICE: “Pinebridge Investments L.P. Has $816,000 Position in Colgate-Palmolive (NYSE:CL)” was originally reported by The Lincolnian Online and is the property of of The Lincolnian Online. If you are accessing this piece on another website, it was illegally copied and republished in violation of international copyright & trademark laws. The original version of this piece can be accessed at https://www.thelincolnianonline.com/2017/12/07/colgate-palmolive-company-cl-shares-sold-by-pinebridge-investments-l-p-updated-updated.html.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.